<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:53 -0700</creation_date>
  <update_date>2013-05-27 11:38:44 -0600</update_date>
  <accession>HMDBP00610</accession>
  <secondary_accessions>
    <accession>5882</accession>
  </secondary_accessions>
  <protein_type>Enzyme</protein_type>
  <synonyms>
    <synonym>Ubiquitin carrier protein D3</synonym>
    <synonym>Ubiquitin-conjugating enzyme E2(17)KB 3</synonym>
    <synonym>Ubiquitin-conjugating enzyme E2-17 kDa 3</synonym>
    <synonym>Ubiquitin-protein ligase D3</synonym>
  </synonyms>
  <gene_name>UBE2D3</gene_name>
  <general_function>Involved in acid-amino acid ligase activity</general_function>
  <specific_function>Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-, as well as 'Lys-48'-linked polyubiquitination. Cooperates with the E2 CDC34 and the SCF(FBXW11) E3 ligase complex for the polyubiquitination of NFKBIA leading to its subsequent proteasomal degradation. Acts as an initiator E2, priming the phosphorylated NFKBIA target at positions 'Lys-21' and/or 'Lys-22' with a monoubiquitin. Ubiquitin chain elongation is then performed by CDC34, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. Acts also as an initiator E2, in conjunction with RNF8, for the priming of PCNA. Monoubiquitination of PCNA, and its subsequent polyubiquitination, are essential events in the operation of the DNA damage tolerance (DDT) pathway that is activated after DNA damage caused by UV or chemical agents during S-phase. Associates with the BRCA1/BARD1 E3 ligase complex to perform ubiquitination at DNA damage sites following ionizing radiation leading to DNA repair. Targets DAPK3 for ubiquitination which influences promyelocytic leukemia protein nuclear body (PML-NB) formation in the nucleus. In conjunction with the MDM2 and TOPORS E3 ligases, functions ubiquitination of p53/TP53. Supports NRDP1-mediated ubiquitination and degradation of ERBB3 and of BRUCE which triggers apoptosis. In conjunction with the CBL E3 ligase, targets EGFR for polyubiquitination at the plasma membrane as well as during its internalization and transport on endosomes. In conjunction with the STUB1 E3 quality control E3 ligase, ubiquitinates unfolded proteins to catalyze their immediate destruction (By similarity).
</specific_function>
  <pathways>
    <pathway>
      <name>protein ubiquitination</name>
      <smpdb_id/>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Ubiquitin mediated proteolysis</name>
      <smpdb_id/>
      <kegg_map_id>map04120</kegg_map_id>
    </pathway>
    <pathway>
      <name>Protein processing in endoplasmic reticulum</name>
      <smpdb_id/>
      <kegg_map_id>map04141</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00045</accession>
      <name>Adenosine monophosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00250</accession>
      <name>Pyrophosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00538</accession>
      <name>Adenosine triphosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02142</accession>
      <name>Phosphoric acid</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>ligase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>ligase activity, forming carbon-nitrogen bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>acid-amino acid ligase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>small conjugating protein ligase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>biological regulation</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of biological process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of macromolecule metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>regulation of protein metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>macromolecule metabolic process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>macromolecule modification</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>protein modification process</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>post-translational protein modification</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytosol</description>
      <go_id>GO:0005829</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>endosome membrane</description>
      <go_id>GO:0010008</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>nucleoplasm</description>
      <go_id>GO:0005654</go_id>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>plasma membrane</description>
      <go_id>GO:0005886</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>ATP binding</description>
      <go_id>GO:0005524</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>ubiquitin-protein ligase activity</description>
      <go_id>GO:0004842</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>apoptotic process</description>
      <go_id>GO:0006915</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>BMP signaling pathway</description>
      <go_id>GO:0030509</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>DNA repair</description>
      <go_id>GO:0006281</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>innate immune response</description>
      <go_id>GO:0045087</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of transcription from RNA polymerase II promoter</description>
      <go_id>GO:0000122</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>negative regulation of type I interferon production</description>
      <go_id>GO:0032480</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>proteasomal ubiquitin-dependent protein catabolic process</description>
      <go_id>GO:0043161</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein K11-linked ubiquitination</description>
      <go_id>GO:0070979</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein K48-linked ubiquitination</description>
      <go_id>GO:0070936</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>protein monoubiquitination</description>
      <go_id>GO:0006513</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>regulation of transcription from RNA polymerase II promoter in response to hypoxia</description>
      <go_id>GO:0061418</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>transcription initiation from RNA polymerase II promoter</description>
      <go_id>GO:0006367</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>transforming growth factor beta receptor signaling pathway</description>
      <go_id>GO:0007179</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Cell membrane</subcellular_location>
    <subcellular_location>Peripheral membrane protein</subcellular_location>
    <subcellular_location>Endosome membrane</subcellular_location>
    <subcellular_location>Peripheral membrane protein</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>4</chromosome_location>
    <locus>4q24</locus>
    <gene_sequence>&gt;444 bp
ATGGCGCTGAAACGGATTAATAAGGAACTTAGTGATTTGGCCCGTGACCCTCCAGCACAA
TGTTCTGCAGGTCCAGTTGGGGATGATATGTTTCATTGGCAAGCCACAATTATGGGACCT
AATGACAGCCCATATCAAGGCGGTGTATTCTTTTTGACAATTCATTTTCCTACAGACTAC
CCCTTCAAACCACCTAAGGTTGCATTTACAACAAGAATTTATCATCCAAATATTAACAGT
AATGGCAGCATTTGTCTCGATATTCTAAGATCACAGTGGTCGCCTGCTTTAACAATTTCT
AAAGTTCTTTTATCCATTTGTTCACTGCTATGTGATCCAAACCCAGATGACCCCCTAGTG
CCAGAGATTGCACGGATCTATAAAACAGACAGAGATAAGTACAACAGAATATCTCGGGAA
TGGACTCAGAAGTATGCCATGTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>147</residue_number>
    <molecular_weight>16686.96</molecular_weight>
    <theoretical_pi>7.804</theoretical_pi>
    <pfams>
      <pfam>
        <name>UQ_con</name>
        <pfam_id>PF00179</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Ubiquitin-conjugating enzyme E2 D3
MALKRINKELSDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDY
PFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLV
PEIARIYKTDRDKYNRISREWTQKYAM</protein_sequence>
  </protein_properties>
  <genbank_protein_id>4507777</genbank_protein_id>
  <uniprot_id>P61077</uniprot_id>
  <uniprot_name>UB2D3_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>1X23</pdb_id>
    <pdb_id>2FUH</pdb_id>
    <pdb_id>3L1Z</pdb_id>
    <pdb_id>3RPG</pdb_id>
    <pdb_id>3UGB</pdb_id>
  </pdb_ids>
  <genbank_gene_id>NM_003340.5</genbank_gene_id>
  <genecard_id>UBE2D3</genecard_id>
  <geneatlas_id>UBE2D3</geneatlas_id>
  <hgnc_id>HGNC:12476</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Jensen JP, Bates PW, Yang M, Vierstra RD, Weissman AM: Identification of a family of closely related human ubiquitin conjugating enzymes. J Biol Chem. 1995 Dec 22;270(51):30408-14.</reference_text>
      <pubmed_id>8530467</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, Kimura K, Makita H, Sekine M, Obayashi M, Nishi T, Shibahara T, Tanaka T, Ishii S, Yamamoto J, Saito K, Kawai Y, Isono Y, Nakamura Y, Nagahari K, Murakami K, Yasuda T, Iwayanagi T, Wagatsuma M, Shiratori A, Sudo H, Hosoiri T, Kaku Y, Kodaira H, Kondo H, Sugawara M, Takahashi M, Kanda K, Yokoi T, Furuya T, Kikkawa E, Omura Y, Abe K, Kamihara K, Katsuta N, Sato K, Tanikawa M, Yamazaki M, Ninomiya K, Ishibashi T, Yamashita H, Murakawa K, Fujimori K, Tanai H, Kimata M, Watanabe M, Hiraoka S, Chiba Y, Ishida S, Ono Y, Takiguchi S, Watanabe S, Yosida M, Hotuta T, Kusano J, Kanehori K, Takahashi-Fujii A, Hara H, Tanase TO, Nomura Y, Togiya S, Komai F, Hara R, Takeuchi K, Arita M, Imose N, Musashino K, Yuuki H, Oshima A, Sasaki N, Aotsuka S, Yoshikawa Y, Matsunawa H, Ichihara T, Shiohata N, Sano S, Moriya S, Momiyama H, Satoh N, Takami S, Terashima Y, Suzuki O, Nakagawa S, Senoh A, Mizoguchi H, Goto Y, Shimizu F, Wakebe H, Hishigaki H, Watanabe T, Sugiyama A, Takemoto M, Kawakami B, Yamazaki M, Watanabe K, Kumagai A, Itakura S, Fukuzumi Y, Fujimori Y, Komiyama M, Tashiro H, Tanigami A, Fujiwara T, Ono T, Yamada K, Fujii Y, Ozaki K, Hirao M, Ohmori Y, Kawabata A, Hikiji T, Kobatake N, Inagaki H, Ikema Y, Okamoto S, Okitani R, Kawakami T, Noguchi S, Itoh T, Shigeta K, Senba T, Matsumura K, Nakajima Y, Mizuno T, Morinaga M, Sasaki M, Togashi T, Oyama M, Hata H, Watanabe M, Komatsu T, Mizushima-Sugano J, Satoh T, Shirai Y, Takahashi Y, Nakagawa K, Okumura K, Nagase T, Nomura N, Kikuchi H, Masuho Y, Yamashita R, Nakai K, Yada T, Nakamura Y, Ohara O, Isogai T, Sugano S: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet. 2004 Jan;36(1):40-5. Epub 2003 Dec 21.</reference_text>
      <pubmed_id>14702039</pubmed_id>
    </reference>
    <reference>
      <reference_text>Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31.</reference_text>
      <pubmed_id>15815621</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gonen H, Bercovich B, Orian A, Carrano A, Takizawa C, Yamanaka K, Pagano M, Iwai K, Ciechanover A: Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha. J Biol Chem. 1999 May 21;274(21):14823-30.</reference_text>
      <pubmed_id>10329681</pubmed_id>
    </reference>
    <reference>
      <reference_text>Murata S, Minami Y, Minami M, Chiba T, Tanaka K: CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein. EMBO Rep. 2001 Dec;2(12):1133-8. Epub 2001 Nov 21.</reference_text>
      <pubmed_id>11743028</pubmed_id>
    </reference>
    <reference>
      <reference_text>Yogosawa S, Miyauchi Y, Honda R, Tanaka H, Yasuda H: Mammalian Numb is a target protein of Mdm2, ubiquitin ligase.  Biochem Biophys Res Commun. 2003 Mar 21;302(4):869-72.</reference_text>
      <pubmed_id>12646252</pubmed_id>
    </reference>
    <reference>
      <reference_text>Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J, Liu LF, Lutzker S, Saleem A, Rubin EH: Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53. J Biol Chem. 2004 Aug 27;279(35):36440-4. Epub 2004 Jul 9.</reference_text>
      <pubmed_id>15247280</pubmed_id>
    </reference>
    <reference>
      <reference_text>Saville MK, Sparks A, Xirodimas DP, Wardrop J, Stevenson LF, Bourdon JC, Woods YL, Lane DP: Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.  J Biol Chem. 2004 Oct 1;279(40):42169-81. Epub 2004 Jul 26.</reference_text>
      <pubmed_id>15280377</pubmed_id>
    </reference>
    <reference>
      <reference_text>Huang J, Huang Q, Zhou X, Shen MM, Yen A, Yu SX, Dong G, Qu K, Huang P, Anderson EM, Daniel-Issakani S, Buller RM, Payan DG, Lu HH: The poxvirus p28 virulence factor is an E3 ubiquitin ligase.  J Biol Chem. 2004 Dec 24;279(52):54110-6. Epub 2004 Oct 20.</reference_text>
      <pubmed_id>15496420</pubmed_id>
    </reference>
    <reference>
      <reference_text>Polanowska J, Martin JS, Garcia-Muse T, Petalcorin MI, Boulton SJ: A conserved pathway to activate BRCA1-dependent ubiquitylation at DNA damage sites. EMBO J. 2006 May 17;25(10):2178-88. Epub 2006 Apr 20.</reference_text>
      <pubmed_id>16628214</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ohbayashi N, Okada K, Kawakami S, Togi S, Sato N, Ikeda O, Kamitani S, Muromoto R, Sekine Y, Kawai T, Akira S, Matsuda T: Physical and functional interactions between ZIP kinase and UbcH5.  Biochem Biophys Res Commun. 2008 Aug 8;372(4):708-12. Epub 2008 Jun 2.</reference_text>
      <pubmed_id>18515077</pubmed_id>
    </reference>
    <reference>
      <reference_text>Zhang S, Chea J, Meng X, Zhou Y, Lee EY, Lee MY: PCNA is ubiquitinated by RNF8.  Cell Cycle. 2008 Nov 1;7(21):3399-404.</reference_text>
      <pubmed_id>18948756</pubmed_id>
    </reference>
    <reference>
      <reference_text>Umebayashi K, Stenmark H, Yoshimori T: Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation. Mol Biol Cell. 2008 Aug;19(8):3454-62. Epub 2008 May 28.</reference_text>
      <pubmed_id>18508924</pubmed_id>
    </reference>
    <reference>
      <reference_text>Saha A, Deshaies RJ: Multimodal activation of the ubiquitin ligase SCF by Nedd8 conjugation.  Mol Cell. 2008 Oct 10;32(1):21-31.</reference_text>
      <pubmed_id>18851830</pubmed_id>
    </reference>
    <reference>
      <reference_text>Kubori T, Hyakutake A, Nagai H: Legionella translocates an E3 ubiquitin ligase that has multiple U-boxes with distinct functions. Mol Microbiol. 2008 Mar;67(6):1307-19. Epub 2008 Feb 13.</reference_text>
      <pubmed_id>18284575</pubmed_id>
    </reference>
    <reference>
      <reference_text>David Y, Ziv T, Admon A, Navon A: The E2 ubiquitin-conjugating enzymes direct polyubiquitination to preferred lysines. J Biol Chem. 2010 Mar 19;285(12):8595-604. Epub 2010 Jan 8.</reference_text>
      <pubmed_id>20061386</pubmed_id>
    </reference>
    <reference>
      <reference_text>Wu K, Kovacev J, Pan ZQ: Priming and extending: a UbcH5/Cdc34 E2 handoff mechanism for polyubiquitination on a SCF substrate. Mol Cell. 2010 Mar 26;37(6):784-96.</reference_text>
      <pubmed_id>20347421</pubmed_id>
    </reference>
    <reference>
      <reference_text>Brzovic PS, Lissounov A, Christensen DE, Hoyt DW, Klevit RE: A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination. Mol Cell. 2006 Mar 17;21(6):873-80.</reference_text>
      <pubmed_id>16543155</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
  </metabolite_references>
</protein>
